Results 211 to 220 of about 588,711 (254)

Hospital efficiency under prospective reimbursement schemes: an empirical assessment for the case of Germany

European Journal of Health Economics, 2014
H. Herwartz, Christoph Strumann
semanticscholar   +1 more source

Hospital responses to incentives in alternative reimbursement systems

Journal of Behavioral Economics, 1985
Robert L. Seidman, Richard G. Frank
openaire   +1 more source

Hospital reimbursement incentives: is there a more effective option?--Part I.

The Journal of medical practice management : MPM, 2013
Based on the fiscal incentives inherent in a nation's hospital reimbursement methodology, it is highly predictable how the nation's healthcare executives will manage their organization's resources. The hospital data presented herein suggest that prospective reimbursement such as with DRGs in Germany and the United States encourages preadmission testing,
openaire   +2 more sources

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Financial management: incentive reimbursement.

Hospitals, 1970
C P, Hardwick, H, Wolfe
openaire   +1 more source

Medicare skilled nursing facility reimbursement and upcoding.

Health Economics, 2014
J. Bowblis, Christopher S. Brunt
semanticscholar   +1 more source

The failure of financial incentive? The seemingly inexorable rise of cesarean section.

Social Science & Medicine (1967), 2014
C. Chen, Tsai-Ching Liu, Bradley Chen, Chung‐Liang Lin   +3 more
semanticscholar   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes?

Expert review of pharmacoeconomics & outcomes research, 2015
A. Mcguire, M. Drummond, Monique Martin, N. Justo   +3 more
semanticscholar   +1 more source